FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

111611000001109: Tritace 1.25mg capsules (Aventis Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16370301000001114 Tritace 1.25mg capsules (Aventis Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16370401000001118 Tritace 1.25mg capsules (Aventis Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tritace 1.25mg capsules (Aventis Pharma) Is a Product containing precisely ramipril 1.25 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) Has active ingredient Ramipril false Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) Is a Tritace true Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) Has specific active ingredient Ramipril true Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tritace 1.25mg capsules (Aventis Pharma) 28 capsule 2 x 14 capsules Is pack of False Tritace 1.25mg capsules (Aventis Pharma) Inferred relationship Existential restriction modifier
Tritace 1.25mg capsules (Aventis Pharma) 28 capsule 2 x 14 capsules Has AMP True Tritace 1.25mg capsules (Aventis Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start